SCHEMBL9301487

SCHEMBL9301487

O=[N+]([O-])c1ccc(OCC(O)CN2CCN(CCCC(c3ccc(C(F)(F)F)cc3)c3ccc(C(F)(F)F)cc3)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 5/20 0.55
TDP1 Q9NUW8 1/20 0.55
LMNA P02545 1/20 0.54
ALDH1A1 P00352 1/20 0.53
MAPT P10636 1/20 0.53
HTT P42858 1/20 0.53
DRD4 P21917 1/20 0.52
CACNA1G O43497 6/20 0.51
HTR1A P08908 1/20 0.50
SCN1A P35498 2/20 0.48
SCN5A Q14524 2/20 0.48
SCN9A Q15858 2/20 0.48
KCNH2 Q12809 4/20 0.48
ENPP2 Q13822 1/20 0.44
KDM4E B2RXH2 1/20 0.44
GLA P06280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9300427 0.90 LMNA (0.59) TDP1LMNAALDH1A1MAPTHTT
SCHEMBL9301158 0.87 CACNA1G (0.67) CYP2D6MAPTCACNA1GSCN1ASCN5A
SCHEMBL9301847 0.81 CACNA1G (0.64) CYP2D6CACNA1GSCN1ASCN5ASCN9A
SCHEMBL9301208 0.81 CYP2D6 (0.61) CYP2D6LMNAMAPTCACNA1GSCN1A
SCHEMBL9187274 0.79 MAPT (0.60) ALDH1A1MAPTCACNA1GKCNH2KDM4E
SCHEMBL9302021 0.79 CYP2D6 (0.58) CYP2D6MAPTCACNA1GSCN1ASCN5A
SCHEMBL9192429 0.77 KCNH2 (0.64) LMNAALDH1A1MAPTDRD4CACNA1G
SCHEMBL9301397 0.76 MAPT (0.57) CYP2D6ALDH1A1MAPTCACNA1GKCNH2
SCHEMBL9301814 0.76 CYP2D6 (0.54) CYP2D6LMNAMAPTCACNA1GSCN1A
SCHEMBL9303300 0.76 L3MBTL1 (0.70) CYP2D6LMNAALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5342839-A Useful for therapy of oxygen deficiency diseases of the brain BASF AKTIENGESELLSCHAFT (DE) 1994-08-30 US disclosed
EP-0435902-A1 2-HYDROXY-3-PHENOXY-PROPYL-SUBSTITUTED PIPERAZINES AND HOMOPIPERAZINES, THEIR MANUFACTURE AND USE. BASF AG (DE) 1991-07-10 EP disclosed
WO-1990003371-A1 2-HYDROXY-3-PHENOXY-PROPYL-SUBSTITUTED PIPERAZINES AND HOMOPIPERAZINES, THEIR MANUFACTURE AND USE BASF AKTIENGESELLSCHAFT (DE) 1990-04-05 WO disclosed